Dr. Min Yan, MD

Dr. Yan practices at Epic Care in Emeryville, California.

Dr. Yan's NPI, 1447499710, was assigned on February 10, 2009. Dr. Yan graduated from Peking Union Medical College in 1998. Dr. Yan holds California license A115562.

Dr. Yan's primary practice is Epic Care, at 1480 64th St, Emeryville, CA 94608 in Alameda County. The practice phone is (925) 778-0679.

Dr. Yan's primary practice is Epic Care in Emeryville, California. Dr. Yan is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is Epic Care. Dmand AI also links Dr. Yan to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yan practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Yan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yan is board certified in hematology by the American Board of Internal Medicine. Dr. Yan is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Yan treats.

CMS data shows 104,424 Medicare services from Dr. Yan across 52 procedure codes in 2024, for 966 Medicare patients. Medicare paid $2,842,670 for them.

CMS counts 966 Medicare patients who saw Dr. Yan in 2024. The largest group is 65 to 74, with 376 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 67% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yan's median patient age at 68, with 61% women.

In 2024, Dr. Yan wrote 1,820 Medicare Part D claims for 321 patients. 67% of them were for generic drugs. CMS names the drug for 1,545 of them, across 39 drugs with 11 or more claims each, at $4,256,557 in total drug cost. In 2023, CMS named 1,788 claims across 43 drugs.

Dr. Yan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yan as offering telehealth.

Dmand AI links 18 papers to Dr. Yan, published from 2009 to 2022. The most frequent topics are Breast Neoplasms, Gene Expression Regulation, Neoplastic and Hydroxyprostaglandin Dehydrogenases. Dr. Yan's most frequent co-authors are Nasser Altorki, MD, Monica Marie Bertagnolli, MD and Barbara A. Parker, MD.

CMS Open Payments shows 1,122 general payments to Dr. Yan from 83 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. AstraZeneca Pharmaceuticals LP paid the most, $16,747. It also lists 4 research payments totaling $1,930 from 2024 to 2025.

Dmand AI lists 3 awards for Dr. Yan, most recently 2nd Place, Resident Research Abstract Competition in 2011.

Dr. Yan graduated from Peking Union Medical College in 1998.

Dr. Yan is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.